Arrowhead Pharmaceuticals, INC. (ARWR) — SC 13G/A Filings
All SC 13G/A filings from Arrowhead Pharmaceuticals, INC.. Browse 5 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (5)
- SC 13G/A Filing — Oct 16, 2024
- SC 13G/A Filing — Apr 10, 2024
-
Vanguard Group Updates 9.4% Stake in Arrowhead Pharma
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment management company, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in Arrowhead Pharmaceuticals -
State Street Corp Amends Passive Stake in Arrowhead Pharma
— Jan 24, 2024
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 24, 2024, disclosing its ownership of Arrowhead Pharmaceuticals Inc. comm -
BlackRock Trims Arrowhead Pharma Stake to 6.6%
— Jan 23, 2024
BlackRock Inc. filed an amended SC 13G/A on January 23, 2024, disclosing its ownership in Arrowhead Pharmaceuticals Inc. As of December 31, 2023, BlackRock repo
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX